Ureaplasma parvum-artritis i knæ, hofte og sacroiliacaled

Translated title of the contribution: Ureaplasma parvum arthritis affecting knee, hip, and sacroiliac joint

Cecilie Hviid Christiansen*, Peter Doering, Jurgita Samulioniené, Hans Linde Nielsen

*Corresponding author for this work

Research output: Contribution to journalJournal articleResearchpeer-review


In this case report a rare case of Ureaplasma parvum arthritis affecting the left knee, hip, and the sacroiliac joint in a 57-year-old woman is investigated. The patient was initially treated with intravenous piperacillin/tazobactam and later on meropenem with no clinical effect. After surgery of the hip and knee, tissue biopsies and synovial fluids were all culture negative. Eventually, Ureaplasma parvum was detected by 16S analysis, and the antibiotic regimen was changed to intravenous moxifloxacin. The patient improved and after four weeks the therapy was changed to lifelong oral therapy with moxifloxacin.
Translated title of the contributionUreaplasma parvum arthritis affecting knee, hip, and sacroiliac joint
Original languageDanish
Article numberV03220161
JournalUgeskrift for Læger
Publication statusPublished - 4 Jul 2022

Bibliographical note

Print edition: Ugeskr Laeger. 2023; 185(1):69-70.


Dive into the research topics of 'Ureaplasma parvum arthritis affecting knee, hip, and sacroiliac joint'. Together they form a unique fingerprint.

Cite this